Skip to main content
Clinical Trials/EUCTR2011-002061-38-BE
EUCTR2011-002061-38-BEActive, not recruitingPhase 1

A randomised prospective trough level monitoring study with real-time therapeutic adaptations: Trough level Adapted infliXImab Treatment scheme (TAXIT). - TAXIT

Katholieke Universiteit Leuven0 sitesStarted: June 8, 2011Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Phase 1
Status
Active, not recruiting

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
All

Inclusion Criteria

  • •- Males and females = 18 and = 64 years of age
  • •- Diagnosis of CD or UC confirmed by endoscopy and histology and in stable clinical remission
  • •- Signed informed consent
  • •- On anti-TNF infliximab maintenance therapy for at least 14 consecutive weeks
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range: 0
  • •F.1.2 Adults (18-64 years) yes
  • •F.1.2.1 Number of subjects for this age range 200
  • •F.1.3 Elderly (>=65 years) no
  • •F.1.3.1 Number of subjects for this age range

Exclusion Criteria

  • •- Not willing to participate in study or not willing to sign inform consent
  • •- Patients included in placebo-controlled trials
  • •- Patients not in stable remission upon entry into the study (designated by symptoms, CRP>5mg/ml and endoscopic lesions)

Investigators

Similar Trials